Search - tctmd.com

Displaying 41 - 60 of 488

Sort: Relevancy | Date

News Daily News

¿Adiós SMD? Nuevos Análisis de la DAPT Evidencian Menos Ocurrencias de Trombosis del Stent Con el SLF

Yael L. Maxwell

October 26, 2015

News Daily News

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

L.A. McKeown

October 26, 2015

News Daily News

Más Noticias Desalentadoras para los BRFs en el Tratamiento de Lesiones Infrapoplíteas

L.A. McKeown

October 26, 2015

News Daily News

Goodbye BMS? New DAPT Analysis Shows Less Stent Thrombosis With DES

Yael L. Maxwell

October 26, 2015

News Daily News

DCB治疗膝下病变又传出令人失望的消息

L.A. McKeown

October 26, 2015

Presentation

Paclitaxel-Coated Balloon in Infrapopliteal Arteries

Presenter: Thomas Zeller

October 23, 2015

Presentation TCT 2015

TUXEDO: A Prospective Randomized Trial of Paclitaxel-Eluting vs Everolimus-Eluting Stents in Diabetic Patients With Coronary Artery Disease

Presenter: Cindy L. Grines, Upendra Kaul

October 14, 2015

Presentation TCT 2015

Early First-in-Human Data of Paclitaxel Drug-Coated Chocolate PTCA Coronary Balloon Catheters in De Novo Coronary Lesions

Presenter: Andrea Abizaid, Daniel Burkhoff, J. A. Mustapha

October 14, 2015

Presentation TCT 2015

TUXEDO: A Prospective Randomized Trial of Paclitaxel-Eluting vs Everolimus-Eluting Stents in Diabetic Patients With Coronary Artery Disease

Presenter: Upendra Kaul

October 14, 2015

News Conference News TCT 2015

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

Todd Neale

October 14, 2015

News Industry News

Randomized Trial Of Diabetic Patients In India Finds Paclitaxel-Eluting Stents Failed To Meet Non-Inferiority Compared To Everolimus-Eluting Stents

October 14, 2015

News Industry News

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

October 14, 2015

News Conference News TCT 2015

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

October 14, 2015

News Conference News TCT 2015

IN.PACT SFA: Benefits of DCB Persist at 2 Years

October 14, 2015

News Conference News TCT 2015

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

October 12, 2015

News Conference News TCT 2015

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

October 12, 2015

News Conference News TCT 2015

BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective

October 12, 2015

News Industry News

QT Vascular Announces Interim Clinical Trial Results Of Chocolate Touch

October 06, 2015

News Industry News

STENTYS Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease

September 29, 2015

News Industry News

QT Vascular wins CE Mark for drug-coated balloon

September 10, 2015

Advertisement

¿Adiós SMD? Nuevos Análisis de la DAPT Evidencian Menos Ocurrencias de Trombosis del Stent Con el SLF

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

Más Noticias Desalentadoras para los BRFs en el Tratamiento de Lesiones Infrapoplíteas

Goodbye BMS? New DAPT Analysis Shows Less Stent Thrombosis With DES

DCB治疗膝下病变又传出令人失望的消息

Paclitaxel-Coated Balloon in Infrapopliteal Arteries

TUXEDO: A Prospective Randomized Trial of Paclitaxel-Eluting vs Everolimus-Eluting Stents in Diabetic Patients With Coronary Artery Disease

Early First-in-Human Data of Paclitaxel Drug-Coated Chocolate PTCA Coronary Balloon Catheters in De Novo Coronary Lesions

TUXEDO: A Prospective Randomized Trial of Paclitaxel-Eluting vs Everolimus-Eluting Stents in Diabetic Patients With Coronary Artery Disease

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

Randomized Trial Of Diabetic Patients In India Finds Paclitaxel-Eluting Stents Failed To Meet Non-Inferiority Compared To Everolimus-Eluting Stents

Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis

ISAR-DESIRE 4: Scoring Balloon Predilation Effective at 1 Year in Patients With DES Restenosis

IN.PACT SFA: Benefits of DCB Persist at 2 Years

Second-Generation DES, DCB Both Strategies for Treating In-Stent Restenosis

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective

QT Vascular Announces Interim Clinical Trial Results Of Chocolate Touch

STENTYS Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease

QT Vascular wins CE Mark for drug-coated balloon

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content